Laboratorios Sophia S.a De C.v.
Clinical trials sponsored by Laboratorios Sophia S.a De C.v., explained in plain language.
-
New eye drug PRO-169 takes on lucentis in major trial
Disease control CompletedThis study tested a new eye medication called PRO-169 against a standard drug (ranibizumab) for people with diabetic macular edema, a condition that causes vision loss in people with diabetes. About 509 adults with diabetes took part, receiving injections into the eye over one ye…
Phase: PHASE3 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Chamomile eye drops challenge standard treatment for eye relief
Symptom relief CompletedThis study tested whether Manzanilla Sophia®, a chamomile-based eye drop, is as good as Meticel Ofteno® 0.5% for relieving eye discomfort caused by other eye drops. 167 adults with eye irritation participated. The main goal was to see if the chamomile drops reduced eye fatigue sc…
Phase: PHASE4 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Which eye drop heals your cornea faster after laser surgery?
Symptom relief CompletedThis study compared two eye drops, Lagricel and Thealoz, to see which helps the cornea heal faster after PRK laser eye surgery. 96 adults who had PRK surgery used one of the drops four times a day for two weeks. The main goal was to measure how quickly the cornea's outer layer cl…
Phase: PHASE4 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Can more drops beat dry eye? new study tests three schedules
Symptom relief CompletedThis Phase 2 study tested three different dosing schedules of Lagricel Ofteno eye drops (sodium hyaluronate 0.4%) in 141 people with mild to moderate dry eye. Participants used the drops either twice, four times, or six times a day. The main goal was to see which schedule best im…
Phase: PHASE2 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Eye drop showdown: which one beats dry eye?
Symptom relief CompletedThis study tested three different eye drops (Humylub Ofteno PF, Hyabak, and Lagricel Ofteno PF) in 182 people with mild to moderate dry eye. Participants used the drops four times a day for 30 days. The main goal was to see if Humylub was as good as the others at reducing dry eye…
Phase: PHASE4 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New eye drops for nearsightedness pass early safety check
Symptom relief CompletedThis early-phase study tested the safety of PRO-201 eye drops (a low-dose atropine solution) in 29 healthy adults aged 18 to 35. The main goal was to see if the drops cause unexpected side effects or light sensitivity. Researchers also checked vision, eye pressure, and comfort. T…
Phase: PHASE1 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New eye gel shows promise for dry eye sufferers
Symptom relief CompletedThis early-stage study tested a new eye gel called PRO-165 to see if it is safe and tolerable for people with dry eyes. 32 healthy adults used either the new gel or a standard lubricating gel. The goal was to check for side effects and comfort, not to cure dry eye.
Phase: PHASE1 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New eye gel passes safety test in cataract surgery trial
Symptom relief CompletedThis study tested a new gel called PRO-149 used during cataract surgery to protect the eye. 36 adults with age-related cataracts received either the new gel or a standard gel during their operation. The main goal was to check safety by measuring changes in eye cell count and pres…
Phase: NA • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New eye drop combo tested for safety in healthy people
Knowledge-focused CompletedThis early-phase study tested whether PRO-232 eye drops, which combine an antibiotic (moxifloxacin) and a steroid (dexamethasone), are safe and tolerable for healthy adults. Twenty-eight volunteers received either the active drops or a placebo. Researchers monitored for unexpecte…
Phase: PHASE1 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC